Delivery Order SPE2DB22D1106-SPE2DB25FDZP3
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Linzess 145 MCG capsules. The contract has a ceiling value of $5,495.02 and runs through August 23, 2023. The contract is a firm fixed-price delivery order, and it does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,427.98 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S and has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,039.78, is for the delivery of the drug Linzess 72 MCG Capsule. The contract is a firm fixed-price, indefinite delivery/indefinite quantity (IDIQ) type, with a period of performance through November 1, 2023. Amerisourcebergen has an existing IDIQ contract with DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of LINZESS 145 MCG capsules. The contract has a firm fixed price of $4,196.85 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of pharmaceutical and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,477.17 firm fixed-price contract is for the supply of LINZESS 145 MCG CAPSULE medical products, with a period of performance through February 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a $5,418.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LINZESS 145 MCG capsules to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,078.48, is for the delivery of LINZESS 290 MCG CAPSULE 30S, a prescription medication. The contract has a firm fixed price pricing type and a period of performance extending through October 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG capsules. The contract has a ceiling value of $1,882.29 and a completion date of September 17, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,554.64 firm-fixed-price contract is for the supply of LINZESS 290 MCG capsules, a prescription medication. It has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG CAPSULE in 30-count units. The $1,740.98 firm-fixed-price contract has a completion date of July 19, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which serves as the primary vehicle for providing pharmaceutical and medical...